SEC Form 4/A · accession 0001209191-18-019990
Protagonist Therapeutics, Inc · PTGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Sarah B. Noonberg
Director
Period of report
Dec 15, 2017
Accepted (ET)
Mar 15, 2018 · 7:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001377121
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $18.99 | Dec 15, 2017 | A | 24,000 | A | — | Dec 14, 2027 | Common Stock | 24,000 | 24,000 | D |
Explanation of responses
- F1This amendment to the previously filed Form 4 is being filed to correct a typographical error in the exercise price of the option to purchase common stock of the Issuer held by the Reporting Person.
- F2The shares subject to the option shall vest in 36 equal monthly installments from the vesting commencement date of December 12, 2017.